Literature DB >> 27207012

Evaluation of the optimal provision of formalin-fixed, paraffin-embedded material for reverse transcription-PCR in soft-tissue tumour diagnosis.

Khin Thway1, Dorte Wren2, Jasmin Lee1, Lisa Thompson2, Cyril Fisher1, David Gonzalez2.   

Abstract

AIMS: Molecular genetic analysis is now a routine ancillary diagnostic modality to the histopathological diagnosis of soft-tissue neoplasms, many of which harbour characteristic gene fusions detectable by reverse transcription-PCR (RT-PCR). As the final diagnosis often depends on the molecular result, it is important to obtain the optimal yield of patient RNA.
METHODS: We assessed the most reliable method of providing formalin-fixed, paraffin-embedded material for optimal RNA yield by comparing three consecutive periods in which different preparations (5×10 μm scrolls, 5×5 μm sections and 1×10 μm sections) were used for RNA extraction for RT-PCR, with its technical success rate.
RESULTS: For '2011', '2012' and '2013', RT-PCR technical failure rates were 13.4%, 4.4% and 7.9%, respectively. The percentage of failed referral cases was 71.4%, 85.7% and 31.3%, and the proportion of core biopsy to excision specimens was 3:15, 2:5 and 13:3.
CONCLUSIONS: This study shows that the effectiveness of RNA extraction and purification is dependent on both specimen type and the tissue sectioning strategy. The failure rate has improved over recent years, particularly for large specimens as large numbers of thick 10 μm scrolls can saturate RNA extraction columns. In contrast, recent technical fails are more frequent in core biopsies, where 1×10 μm sections are insufficient for adequate RNA extraction. While previous technical fails occurred mostly in referred cases, this appears no longer the case due to the better fixation and processing of specimens in external surgical pathology departments because of the widespread recognition of the importance of molecular diagnostics as an important part of the patient pathway. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  GENETICS; HISTOPATHOLOGY; PCR; SARCOMAS; SOFT TISSUE TUMOURS

Mesh:

Substances:

Year:  2016        PMID: 27207012     DOI: 10.1136/jclinpath-2016-203691

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Desmoplastic small round cell tumor: evaluation of reverse transcription-polymerase chain reaction and fluorescence in situ hybridization as ancillary molecular diagnostic techniques.

Authors:  Mustafa Mohamed; David Gonzalez; Karen J Fritchie; John Swansbury; Dorte Wren; Charlotte Benson; Robin L Jones; Cyril Fisher; Khin Thway
Journal:  Virchows Arch       Date:  2017-07-26       Impact factor: 4.064

2.  The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.

Authors:  Jonathan Noujaim; Robin L Jones; John Swansbury; David Gonzalez; Charlotte Benson; Ian Judson; Cyril Fisher; Khin Thway
Journal:  Br J Cancer       Date:  2017-01-31       Impact factor: 7.640

3.  Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours.

Authors:  Elisa Izquierdo; Lina Yuan; Sally George; Michael Hubank; Chris Jones; Paula Proszek; Janet Shipley; Susanne A Gatz; Caedyn Stinson; Andrew S Moore; Steven C Clifford; Debbie Hicks; Janet C Lindsey; Rebecca M Hill; Thomas S Jacques; Jane Chalker; Khin Thway; Simon O'Connor; Lynley Marshall; Lucas Moreno; Andrew Pearson; Louis Chesler; Brian A Walker; David Gonzalez De Castro
Journal:  Oncotarget       Date:  2017-12-06

4.  Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens.

Authors:  Margaret A Hay; Eric A Severson; Vincent A Miller; David A Liebner; Jo-Anne Vergilio; Sherri Z Millis; James L Chen
Journal:  JCO Precis Oncol       Date:  2020-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.